Evidence map›Paper›PMID 32886123›Full record

ArticleJAMA network open2020

Assessment of Probable Opioid Use Disorder Using Electronic Health Record Documentation.

Sarah A Palumbo, Kayleigh M Adamson, Sarathbabu Krishnamurthy, Shivani Manoharan, Donielle Beiler, Anthony Seiwell, Colt Young, Raghu Metpally, Richard C Crist, Glenn A Doyle and 5 more

Abstract read
In one paragraph

Article in JAMA network open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Identifying Opioid Overdose and Opioid Use Disorder and Related Information from Clinical Narratives Using Large Language Models.AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science · 2025
    Article
  12. Observational
  13. Evaluation of an emergency department-based approach to reduce subsequent opioid overdoses.Journal of the American College of Emergency Physicians open · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sarah A PalumboDepartment of Biomedical Science, Schmidt College of Medicine of Florida Atlantic University, Boca Raton.
Kayleigh M AdamsonGeisinger Clinic, Geisinger, Danville, Pennsylvania.
Sarathbabu KrishnamurthyDepartment of Molecular and Functional Genomics, Geisinger, Danville, Pennsylvania.
Shivani ManoharanGeisinger Clinic, Geisinger, Danville, Pennsylvania.
Donielle BeilerGeisinger Clinic, Geisinger, Danville, Pennsylvania.
Anthony SeiwellGeisinger Clinic, Geisinger, Danville, Pennsylvania.
Colt YoungGeisinger Clinic, Geisinger, Danville, Pennsylvania.
Raghu MetpallyDepartment of Molecular and Functional Genomics, Geisinger, Danville, Pennsylvania.
Richard C CristCenter for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Glenn A DoyleCenter for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Thomas N FerraroCenter for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Mingyao LiDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia.
Wade H BerrettiniGeisinger Clinic, Geisinger, Danville, Pennsylvania.
Janet D RobishawDepartment of Biomedical Science, Schmidt College of Medicine of Florida Atlantic University, Boca Raton.
Vanessa TroianiGeisinger Clinic, Geisinger, Danville, Pennsylvania.

Funding

Supplemental Application for Clinical and Genetic Risk Profile of Opioid Use DisorderR01DA044015 · NIDA · GEISINGER CLINIC · PI BERRETTINI, WADE H, ROBISHAW, JANET D · 2017 to 2021
$4.5M
NIDA NIH HHS R01 DA044015
6 · The paper itself

Abstract

Importance: Electronic health records are a potentially valuable source of information for identifying patients with opioid use disorder (OUD). Objective: To evaluate whether proxy measures from electronic health record data can be used reliably to identify patients with probable OUD based on Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) (DSM-5) criteria. Design, Setting, and Participants: This retrospective cross-sectional study analyzed individuals within the Geisinger health system who were prescribed opioids between December 31, 2000, and May 31, 2017, using a mixed-methods approach. The cohort was identified from 16 253 patients enrolled in a contract-based, Geisinger-specific medication monitoring program (GMMP) for opioid use, including patients who maintained or violated contract terms, as well as a demographically matched control group of 16 253 patients who were prescribed opioids but not enrolled in the GMMP. Substance use diagnoses and psychiatric comorbidities were assessed using automated electronic health record summaries. A manual medical record review procedure using DSM-5 criteria for OUD was completed for a subset of patients. The analysis was conducted beginning from June 5, 2017, until May 29, 2020. Main Outcomes and Measures: The primary outcome was the prevalence of OUD as defined by proxy measures for DSM-5 criteria for OUD as well as the prevalence of comorbidities among patients prescribed opioids within an integrated health system. Results: Among the 16 253 patients enrolled in the GMMP (9309 women [57%]; mean [SD] age, 52 [14] years), OUD diagnoses as defined by diagnostic codes were present at a much lower rate than expected (291 [2%]), indicating the necessity for alternative diagnostic strategies. The DSM-5 criteria for OUD can be assessed using manual medical record review; a manual review of 200 patients in the GMMP and 200 control patients identifed a larger percentage of patients with probable moderate to severe OUD (GMMP, 145 of 200 [73%]; and control, 27 of 200 [14%]) compared with the prevalence of OUD assessed using diagnostic codes. Conclusions and Relevance: These results suggest that patients with OUD may be identified using information available in the electronic health record, even when diagnostic codes do not reflect this diagnosis. Furthermore, the study demonstrates the utility of coding for DSM-5 criteria from medical records to generate a quantitative DSM-5 score that is associated with OUD severity.

Indexed as

AdultAgedCross-Sectional StudiesDocumentationElectronic Health RecordsFemaleHumansMaleMiddle AgedOpioid-Related DisordersPrevalenceRetrospective Studies

Identifiers

PMID32886123
PMCPMC7489858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.